Article
Serum Myeloperoxidase as a Biomarker of Asthma Severity Among Adults: A Case Control Study
1 Apr 2022
Abstract excerpt
Background: The contribution of neutrophils is still indistinct in the inflammatory response of bronchial asthma (BAs). Myeloperoxidase (MPO) is an enzyme released from the primary azurophilic granules of the neutrophils. The study aimed to evaluate the levels of serum MPO as a biomarker for the assessment of the level of asthma control. Methods: The study participants included 94 asthmatic patients and 86...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
